US equities |
NVDA $221.30 ▼-3.16% MU $914.13 ▼-4.10% AAPL $342.96 ▲+0.50% AMD $570.82 ▼-5.73% META $737.54 ▼-3.27% MSFT $533.69 ▼-1.80% TSLA $367.16 ▼-2.15% SPCX $152.16 ▼-2.80%
FinancialContent

Latest News about Florian Brand

Recent news which mentions Florian Brand

Atai's DMT Depression Drug Shows Promise, Prepares For Phase II Trial And Future Collaboration With Pharma Giant
Tickers ATAI
Tags ATAI Life Sciences Benzinga DMT/Assisted Therapy
From Benzinga
Atai Life Sciences' Q3 Earnings: Near $20M Burned QoQ, Says Funding 'Sufficient' To Streamline 2026
Tickers ATAI CMPS
Tags Penny Stocks Florian Brand News
From Benzinga
Atai Launches Phase 1 Clinical Trial On Novel Direct-To-Brain Drug Delivery Technology
Tickers ATAI
Tags ATAI Small Cap Markets
From Benzinga
Novel Psychedelic Compound Show Positive Results For Opioid Use Disorder Treatment
Tickers ATAI
Tags Florian Brand opioid abuse Penny Stocks
From Benzinga
Major Goals For ATAI: $175M Secured In Term Loan Facility, Plus Q2 Earnings Report
Tickers ATAI HTGC
Tags Florian Brand Penny Stocks Management
From Benzinga
Atai Life Sciences: Capital Raise, Share Options, Cathy Wood And More On Biotech Psychedelics Leader
Tickers ATAI
Tags News Cannabis Market News
From Benzinga
EXCLUSIVE: Atai Life Sciences Posts Earnings for Q1 2022, Advancing Key Milestones In Psychedelic Drug Development
Tickers ATAI
Tags Benzinga Srinivas Rao/ Small Cap
From Benzinga
Can Ketamine For Depression Be Improved? New Study Will Looks Into Ketamine Analog Arketamine
Tickers ATAI JNJ
Tags Markets ATAI Market News
From Benzinga